Over-evaluated medical device companies with 4.5 PBR

It was known that the price-to-book ratio(PBR) of domestic medical device companies is estimated at 4.5 in average, becoming much higher than the ratio of the pharmaceutical industry.

According to the analysis result of 20 domestic listed medical device companies’ market capitalizations(as of the 30^th of September) and net asset values(in the first half of the year), conducted by PharmScore, a...